U.S. Stocks Rally Over 15% in Q2 2026: AI Stocks Still Run
U.S. equities closed the second quarter with a double‑digit rally, led by AI-driven tech names. Yet analysts warn tha...
Ways To Balance Budget With Unexpected Costs
Get concise guidance on balancing a budget amid surprises, including flexible categories and a small emergency cushion.
25,157 articles
Starboard’s Dynatrace Play: Activist Turnaround or Sale
Starboard Value’s effort at Dynatrace tests whether the observability software maker can turn around on its own or be...
Costco Pricing Secret That Keeps It Unusually Cheap
Costco blends a lean merchandise line with a robust membership model to outpace rivals. The costco pricing secret tha...
Rubio Blames Brazil’s Tariffs as Markets React to Policy
The United States is imposing 25% tariffs on imports from Brazil, with exemptions for key items like coffee and beef....
Portfolio That Lets Cruise Through Changing Markets Today
Investors turn to a resilient, income-focused mix to weather headlines and market swings in 2026. A practical framewo...
Million Veris Residential Stock Bet: 1.2M Share Move
A large insider stake in Veris Residential stock signals conviction from an established manager. This article explain...
Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Lilly Just Took Major Steps Forward in Obesity Drug Market
Two bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
Wayfair Co-Founder Sells $2.1 Million Ahead of Expansion
A Wayfair co-founder recently sold a substantial stake, signaling a strategic portfolio reshuffle amid ambitious expa...
Uber Dara Khosrowshahi Rejects Coasting, Demands Email
Uber is moving away from the idea of a laid-back culture. CEO Dara Khosrowshahi asserts a relentless work ethic, even...
Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Months, This High-Yield Dividend: Still a Buy in March?
A high-yield dividend stock jumped about 31% over three months. As March begins, investors must weigh income potentia...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status